SGTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 6.50%

Insider Buying (Last 12 Months): $25,639,915.56

Insider Selling (Last 12 Months): $0.00

Sigilon Therapeutics Insider Trading History Chart

Sigilon Therapeutics Share Price & Price History

^$22.47

▼ -0.59 (-2.56%)

As of 08/11/2023 09:00 PM ET

Move Your Money Before May 22

From Stansberry Research | Ad

The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

Sigilon Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/11/2023	Lilly & Co Eli	Major Shareholder	Buy	1,718,493	$14.92	$25,639,915.56	100
6/2/2021	Daniel Griffith Anderson	Director	Sell	15,384	$130.00	$1,999,920.00	155,555

These AI trades triggered this morning (545% return)

From Prosper Trading Academy | Ad

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

SEC Filings (Institutional Ownership Changes) for Sigilon Therapeutics (NASDAQ:SGTX)

Institutional Buying and Selling by Quarter

Sigilon Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/9/2023	Canada Pension Plan Investment Board	114,244	$2.57M	0.0%	-92.3%	4.566%
5/1/2023	Virtu Financial LLC	27,596	$26K	0.0%	+148.2%	0.085%
2/10/2022	Acadian Asset Management LLC	11,100	$30K	0.0%	N/A	0.034%
1/18/2022	Soundmark Wealth Management LLC	25,555	$71K	0.0%	-49.5%	0.079%
11/12/2021	Geode Capital Management LLC	231,662	$1.31M	0.0%	+73.2%	0.723%
11/10/2021	American Century Companies Inc.	359,688	$2.03M	0.0%	+10.7%	1.122%
11/10/2021	Goldman Sachs Group Inc.	47,860	$0.27M	0.0%	+42.6%	0.149%
11/10/2021	Healthcare of Ontario Pension Plan Trust Fund	229,500	$1.30M	0.0%	N/A	0.716%
11/9/2021	BlackRock Inc.	1,740,942	$9.84M	0.0%	+24.0%	5.430%
11/4/2021	Choate Investment Advisors	66,666	$0.38M	0.0%	N/A	0.208%
11/4/2021	Deutsche Bank AG	19,008	$0.11M	0.0%	+303.5%	0.059%
10/13/2021	Soundmark Wealth Management LLC	50,555	$0.29M	0.1%	-9.0%	0.158%
8/17/2021	Walleye Capital LLC	32,050	$0.34M	0.0%	N/A	0.100%
8/16/2021	Squarepoint Ops LLC	20,300	$0.22M	0.0%	-22.2%	0.063%
8/16/2021	Cubist Systematic Strategies LLC	19,391	$0.21M	0.0%	N/A	0.060%
8/16/2021	Morgan Stanley	546,942	$5.87M	0.0%	+26,803.2%	1.706%
8/16/2021	Charles Schwab Investment Management Inc.	43,873	$0.47M	0.0%	-11.3%	0.137%
8/16/2021	State Street Corp	128,428	$1.38M	0.0%	+68.2%	0.401%
8/16/2021	Nuveen Asset Management LLC	24,363	$0.26M	0.0%	+94.9%	0.076%
8/16/2021	Goldman Sachs Group Inc.	33,552	$0.36M	0.0%	+70.8%	0.105%
8/13/2021	Northern Trust Corp	74,303	$0.80M	0.0%	-12.0%	0.232%
8/13/2021	Jump Financial LLC	15,200	$0.16M	0.0%	N/A	0.048%
8/13/2021	Philadelphia Trust Co.	45,000	$0.48M	0.0%	-44.4%	0.143%
8/13/2021	Geode Capital Management LLC	133,775	$1.44M	0.0%	+9.7%	0.424%
8/13/2021	Vanguard Group Inc.	357,807	$3.84M	0.0%	-3.0%	1.135%
8/13/2021	FMR LLC	773,000	$8.29M	0.0%	-4.7%	2.452%
8/12/2021	Trexquant Investment LP	11,293	$0.12M	0.0%	N/A	0.036%
8/12/2021	JPMorgan Chase & Co.	118,468	$1.27M	0.0%	-13.1%	0.376%
8/12/2021	Monashee Investment Management LLC	317,460	$3.41M	0.4%	N/A	1.007%
8/11/2021	Bank of New York Mellon Corp	27,047	$0.29M	0.0%	+56.5%	0.086%
8/11/2021	BlackRock Inc.	1,404,284	$15.07M	0.0%	+9.3%	4.454%
8/11/2021	Deutsche Bank AG	4,711	$51K	0.0%	-70.1%	0.015%
8/5/2021	American Century Companies Inc.	324,882	$3.49M	0.0%	+69.1%	1.030%
8/3/2021	Victory Capital Management Inc.	61,190	$0.66M	0.0%	-6.0%	0.194%
8/2/2021	New York State Common Retirement Fund	6,863	$74K	0.0%	+137.6%	0.022%
7/31/2021	Zweig DiMenna Associates LLC	118,504	$1.27M	0.1%	+14.8%	0.376%
7/31/2021	Soundmark Wealth Management LLC	55,555	$0.60M	0.2%	N/A	0.176%
5/21/2021	Citadel Advisors LLC	9,147	$0.20M	0.0%	N/A	0.029%
5/19/2021	Squarepoint Ops LLC	26,084	$0.58M	0.0%	-34.8%	0.083%
5/18/2021	Millennium Management LLC	104,101	$2.33M	0.0%	-7.4%	0.330%
5/18/2021	Citadel Advisors LLC	9,147	$0.20M	0.0%	N/A	0.029%
5/18/2021	California State Teachers Retirement System	11,645	$0.26M	0.0%	N/A	0.037%
5/17/2021	Royal Bank of Canada	1,224	$27K	0.0%	N/A	0.004%
5/17/2021	Woodline Partners LP	34,200	$0.76M	0.0%	+5.4%	0.108%
5/17/2021	Nuveen Asset Management LLC	12,499	$0.28M	0.0%	N/A	0.040%
5/17/2021	Gilder Gagnon Howe & Co. LLC	654,209	$14.62M	0.1%	-1.2%	2.075%
5/17/2021	Sphera Funds Management LTD.	362,239	$8.07M	0.6%	-36.2%	1.149%
5/17/2021	Goldman Sachs Group Inc.	19,649	$0.44M	0.0%	-43.9%	0.062%
5/14/2021	UBS Asset Management Americas Inc.	123,374	$2.76M	0.0%	-1.3%	0.391%
5/13/2021	Bank of New York Mellon Corp	17,281	$0.39M	0.0%	N/A	0.055%
5/12/2021	Northern Trust Corp	84,394	$1.89M	0.0%	N/A	0.268%
5/12/2021	Geode Capital Management LLC	121,940	$2.73M	0.0%	+620.3%	0.387%
5/12/2021	Ensign Peak Advisors Inc	13,500	$0.30M	0.0%	N/A	0.043%
5/12/2021	JPMorgan Chase & Co.	136,366	$3.05M	0.0%	N/A	0.433%
5/12/2021	UBS Group AG	1,536	$34K	0.0%	+197.1%	0.005%
5/11/2021	New York State Common Retirement Fund	2,888	$65K	0.0%	N/A	0.009%
5/7/2021	BlackRock Inc.	1,284,848	$28.72M	0.0%	+15.6%	4.075%
5/7/2021	American International Group Inc.	4,500	$0.10M	0.0%	N/A	0.014%
5/4/2021	Victory Capital Management Inc.	65,070	$1.45M	0.0%	-4.3%	0.206%
4/26/2021	Zweig DiMenna Associates LLC	103,200	$2.31M	0.2%	+1,564.5%	0.328%
4/23/2021	Strs Ohio	1,900	$42K	0.0%	N/A	0.006%
3/10/2021	HM Payson & Co.	1,028	$49K	0.0%	N/A	0.003%
3/2/2021	Norges Bank	7,500	$0.36M	0.0%	N/A	0.025%
3/1/2021	UBS Asset Management Americas Inc.	125,000	$6M	0.0%	N/A	0.414%
2/17/2021	Canada Pension Plan Investment Board	1,485,185	$71.33M	0.1%	N/A	4.919%
2/16/2021	Flagship Pioneering Inc.	10,370,369	$498.09M	9.1%	N/A	34.350%
2/16/2021	Squarepoint Ops LLC	40,000	$1.92M	0.0%	N/A	0.132%
2/16/2021	Pura Vida Investments LLC	24,722	$1.19M	0.0%	N/A	0.082%
2/16/2021	Tudor Investment Corp Et Al	7,700	$0.37M	0.0%	N/A	0.026%
2/16/2021	Davidson Kempner Capital Management LP	10,000	$0.47M	0.0%	N/A	0.033%
2/16/2021	Avidity Partners Management LP	688,000	$33.05M	1.1%	N/A	2.279%
2/16/2021	ExodusPoint Capital Management LP	16,246	$0.78M	0.0%	N/A	0.054%
2/16/2021	HarbourVest Partners LLC	740,740	$35.58M	13.9%	N/A	2.454%
2/12/2021	Caas Capital Management LP	35,000	$1.68M	0.0%	N/A	0.116%
2/12/2021	Laurion Capital Management LP	10,000	$0.48M	0.0%	N/A	0.033%
2/11/2021	Citigroup Inc.	9,524	$0.46M	0.0%	N/A	0.032%
2/11/2021	Artal Group S.A.	276,000	$13.26M	0.3%	N/A	0.914%
2/11/2021	Teacher Retirement System of Texas	30,000	$1.44M	0.0%	N/A	0.099%
2/11/2021	Monashee Investment Management LLC	561,628	$26.98M	3.6%	N/A	1.860%
2/8/2021	Philadelphia Trust Co.	13,644	$0.66M	0.1%	N/A	0.045%
2/5/2021	BlackRock Inc.	1,111,888	$53.40M	0.0%	N/A	3.683%
2/5/2021	SG Americas Securities LLC	7,800	$0.38M	0.0%	N/A	0.026%
2/4/2021	State of Wisconsin Investment Board	509,629	$24.48M	0.1%	N/A	1.688%
2/1/2021	Victory Capital Management Inc.	68,000	$3.27M	0.0%	N/A	0.225%

Data available starting January 2016

Sigilon Therapeutics, Inc., a preclinical stage biotechnology company, develops functional cures for patients with acute and chronic diseases. Its lead product candidate is SIG-002 to replace islet cells for the treatment of type 1 diabetes; and SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-205, SIG-218, SIG-220, and SIG-005, which are to treat the non-neurological manifestations of mucopolysaccharidosis type 1; and SIG-207 is to treat of Fabry disease. Sigilon Therapeutics, Inc. has a research collaboration and license agreement with Eli Lilly and Company for the development and commercialization of SLTx product candidates for the treatment of Type 1 Diabetes. The company was formerly known as Sigilon, Inc. and changed its name to Sigilon Therapeutics, Inc. in June 2017. Sigilon Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $22.47

$22.09

$23.10

50 Day Range

MA: $22.02

$20.92

$23.06

52 Week Range

Now: $22.47

$3.77

$28.00

Volume

83,600 shs

Average Volume

62,902 shs

Market Capitalization

$56.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

4.12

Who are the company insiders with the largest holdings of Sigilon Therapeutics?: Sigilon Therapeutics' top insider investors include:
Lilly & Co Eli (Major Shareholder)
Learn More about top insider investors at Sigilon Therapeutics.